ProKidney Corp.
PROK • NASDAQ
ProKidney Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bruce Culleton, with a market cap of $269.7M.
Market Cap$269.7M
Employees163.0
CEOBruce Culleton
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
PRO
ProKidney Corp. FAQ
Common questions about ProKidney Corp.
ProKidney Corp. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $88.2K.
ProKidney Corp. has approximately 163 employees.